VIDA Diagnostics Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
68
- Latest Deal Type
-
Later Stage VC
- Investors
-
22
VIDA Diagnostics General Information
Description
Operator of an Artificial Intelligence (AI) driven imaging platform designed to enhance data quality and accelerate drug development in life sciences. The company offers clinical trial services, including high-quality imaging, efficient site operations, AI-powered insights, and integrated clinical data, enabling pharmaceutical companies and research organizations to get faster approvals, better biomarker targeting, and improved trial outcomes.
Contact Information
Website
vidaintelligence.aiCorporate Office
- 2500 Crosspark Road
- W211 BioVentures Center
- Coralville, IA 52241
- United States
Corporate Office
- 2500 Crosspark Road
- W211 BioVentures Center
- Coralville, IA 52241
- United States
VIDA Diagnostics Timeline
VIDA Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Later Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 17. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 16. Debt - General | Completed | Generating Revenue | ||||
| 15. Later Stage VC (Series D) | 29-Sep-2023 | Completed | Generating Revenue | |||
| 14. Debt - General | 01-Apr-2022 | Completed | Generating Revenue | |||
| 13. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series C) | 09-Apr-2020 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B1) | 01-Jan-2017 | Completed | Generating Revenue | |||
| 10. Grant | 13-Dec-2016 | $325K | $8.5M | Completed | Generating Revenue | |
| 9. Later Stage VC (Series B) | 07-Dec-2016 | $6.14M | $8.5M | Completed | Generating Revenue |
VIDA Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 312,500 | $0.000100 | $0.2 | $4 | $4 | 1x | $2.58 | 1.63% |
| Series A | 529,046 | $0.000100 | $0.1 | $2.1 | $2.1 | 1x | $1.72 | 2.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VIDA Diagnostics Comparisons
Industry
Financing
Details
VIDA Diagnostics Competitors (20)
One of VIDA Diagnostics’s 20 competitors is Unlearn, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Unlearn | Venture Capital-Backed | San Francisco, CA | ||||
| Imaging Endpoints | Corporation | Scottsdale, AZ | ||||
| Caris Life Sciences | Formerly PE-Backed | Irving, TX | ||||
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| Genomic Expression | Venture Capital-Backed | Beverly, MA |
VIDA Diagnostics Patents
VIDA Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250352159-A1 | Method of quantifying and scoring lung mucus plugs | Pending | 17-May-2024 | ||
| US-20240386552-A1 | Method of quantifying lung disease | Pending | 18-May-2023 | ||
| WO-2024238757-A1 | Method of quantifying lung disease | Inactive | 18-May-2023 | ||
| US-20230363730-A1 | Airway mucus visualization | Inactive | 13-May-2022 | ||
| US-12266111-B2 | Visualization of sub-pleural regions | Active | 27-Nov-2020 | G06T7/0016 |
VIDA Diagnostics Signals
VIDA Diagnostics Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BroadOak Capital Partners | Growth/Expansion | |||
| Daybreak Partners | Venture Capital | Minority | ||
| InnoVenture Iowa | Venture Capital | Minority | ||
| Listwin Ventures | Venture Capital | Minority | ||
| Mathers Associates | Family Office | Minority |
VIDA Diagnostics FAQs
-
When was VIDA Diagnostics founded?
VIDA Diagnostics was founded in 2004.
-
Where is VIDA Diagnostics headquartered?
VIDA Diagnostics is headquartered in Coralville, IA.
-
What is the size of VIDA Diagnostics?
VIDA Diagnostics has 68 total employees.
-
What industry is VIDA Diagnostics in?
VIDA Diagnostics’s primary industry is Discovery Tools (Healthcare).
-
Is VIDA Diagnostics a private or public company?
VIDA Diagnostics is a Private company.
-
What is VIDA Diagnostics’s current revenue?
The current revenue for VIDA Diagnostics is .
-
How much funding has VIDA Diagnostics raised over time?
VIDA Diagnostics has raised $44.2M.
-
Who are VIDA Diagnostics’s investors?
BroadOak Capital Partners, Daybreak Partners, InnoVenture Iowa, Listwin Ventures, and Mathers Associates are 5 of 22 investors who have invested in VIDA Diagnostics.
-
Who are VIDA Diagnostics’s competitors?
Unlearn, Imaging Endpoints, Caris Life Sciences, Ambry Genetics, and Genomic Expression are some of the 20 competitors of VIDA Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process